Serum fetuin-A levels inversely correlate with the severity of arterial calcification in patients with chronic lower extremity atherosclerosis without renal disease

International Angiology

Volumn 30, Issue 5, 2011, Pages 474-480

  Szeberin, Z ^a   Fehervari M ^a   Krepuska, M ^a   Apor, A ^a   Rimely, E ^a   Sarkadi, H ^a   Szeplaki G ^a   Prohaszka Z ^a   Kalabay, L ^a   Acsady G ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Atherosclerosis; Calcification, physiologic; Vascular diseases

Indexed keywords

ALBUMIN; FETUIN A; HEMOGLOBIN A1C; TRANSFERRIN;

ABDOMINAL AORTA; ADULT; AGE DISTRIBUTION; AGED; ANGIOGRAPHY; ANKLE BRACHIAL INDEX; AORTA VALVE; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHRONIC LOWER EXTREMITY ATHEROSCLEROSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; HUMAN; KIDNEY FUNCTION; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; PERIPHERAL VASCULAR DISEASE; PROTEIN BLOOD LEVEL; RISK FACTOR; SCORING SYSTEM; SEX RATIO;

AGED; ALPHA-2-HS-GLYCOPROTEIN; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CALCINOSIS; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; HUNGARY; LOGISTIC MODELS; LOWER EXTREMITY; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY, DOPPLER;

EID: 80755169691     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cozzolino M, Mazzaferro S, Pugliese F, Brancaccio D. Vascular calcification and uremia: what do we know? Am J Nephrol 2008;28:339-46.
2. Fiore CE, Celotta G, Politi GG, Di Pino L, Castelli Z, Mangiafico RA et al. Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. Atherosclerosis 2007;195:110-5. (Pubitemid 47561928)
3. Schafer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66. (Pubitemid 38063764)
4. Westenfeld R, Schafer C, Smeets R, Brandenburg VM, Floege J, Ketteler M et al. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 2007;22:1537-46. (Pubitemid 47073751)
5. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004;95:560-7. (Pubitemid 39274370)
6. Mazzaferro S, Pasquali M, Pugliese F, Barresi G, Carbone I, Francone M et al. Serum levels of calcification inhibition proteins and coronary artery calcium score:comparison between transplantation and dialysis. Am J Nephrol 2007;27:75-83. (Pubitemid 46364544)
7. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis:a cross-sectional study. Lancet 2003;361:827-33. (Pubitemid 36331846)
8. Mehrotra R, Westenfeld R, Christenson P, Budoff M, Ipp E, Takasu J et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy:relationship with coronary artery calcification. Kidney Int 2005;67:1070-7. (Pubitemid 41623332)
9. Ix JH, Shlipak MG, Sarnak MJ, Beck GJ, Greene T, Wang X et al. Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int 2007;72:1394-9. (Pubitemid 350126783)
10. Ix JH, Chertow GM, Shlipak MG, Brandenburg VM, Ketteler M, Whooley MA. Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease:data from the Heart and Soul Study. Circulation 2007;115:2533-9. (Pubitemid 46763227)
11. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008;118:2555-62.
12. Mori K, Emoto M, Araki T, Yokoyama H, Teramura M, Lee E et al. Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 2007;66:246-50. (Pubitemid 46096145)
13. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality:a meta-analysis. Jama 2008;300:197-208. (Pubitemid 351969304)
14. Espinola-Klein C, Rupprecht HJ, Bickel C, Lackner K, Sawidis S, Messow CM et al. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation 2008;118:961-7.
15. Higgins CL, Marvel SA, Morrisett JD. Quantification of calcification in atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2005;25:1567-76. (Pubitemid 41098923)
16. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI et al. Carotid artery stenosis:gray-scale and Doppler US diagnosis-Society of Radiologists in Ultrasound Consensus Conference. Radiology 2003;229:340-6. (Pubitemid 37310815)
17. Cozzolino M, Galassi A, Biondi ML, Turri O, Papagni S, Mongelli N et al. Serum fetuin-A levels link inflammation and cardiovascular calcification in hemodialysis patients. Am J Nephrol 2006;26:423-9. (Pubitemid 44971732)
18. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-21. (Pubitemid 30410374)
19. Bollinger A, Breddin K, Hess H, Heystraten FM, Kollath J, Konttila A et al. Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images. Atherosclerosis. 1981;38:339-46. (Pubitemid 11166896)
20. Kalabay L, Jakab L, Prohaszka Z, Fust G, Benko Z, Telegdy L et al. Human fetuin/alpha2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. Eur J Gastroenterol Hepatol 2002;14:389-94. (Pubitemid 34439037)
21. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet 2005;366:1059-62. (Pubitemid 41338752)
22. Eraso LH, Ginwala N, Qasim AN, Mehta NN, Dlugash R, Kapoor S et al. Association of Lower Plasma Fetuin-A Levels with Peripheral Arterial Disease in Type-2 Diabetes. Diabetes Care 2009;12:12.
23. Emoto M, Mori K, Lee E, Kawano N, Yamazaki Y, Tsuchikura S et al. Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus. Metabolism 2009;14:14.
24. Rittig K, Thamer C, Haupt A, Machann J, Peter A, Balletshofer B et al. High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. Atherosclerosis 2009;207:341-2.
25. Koos R, Brandenburg V, Mahnken AH, Muhlenbruch G, Stanzel S, Gunther RW et al. Association of fetuin-A levels with the progression of aortic valve calcification in non-dialyzed patients. Eur Heart J 2009;30:2054-61.
26. Cianciolo G, La Manna G, Donati G, Persici E, Dormi A, Cappuccilli ML et al. Coronary Calcifications in End-Stage Renal Disease Patients:A New Link between Osteoprotegerin, Diabetes and Body Mass Index? Blood Purif 2009;29:13-22.
27. Mori K, Ikari Y, Jono S, Emoto M, Shioi A, Koyama H et al. Fetuin-A is associated with calcified coronary artery disease. Coron Artery Dis. 10.1097/MCA. 0b013e-32832fe5d5.
28. Ziegler S, Kudlacek S, Luger A, Minar E. Osteoprotegerin plasma concentrations correlate with severity of peripheral artery disease. Atherosclerosis 2005;182:175-80. (Pubitemid 41188384)
29. Ix JH, Wassel CL, Kanaya AM, Vittinghoff E, Johnson KC, Koster A et al. Fetuin-A and incident diabetes mellitus in older persons. Jama 2008;300:182-8. (Pubitemid 351969302)
30. Jahnen-Dechent W, Schafer C, Ketteler M, McKee MD. Mineral chaperones:a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification. J Mol Med 2008;86:379-89.